Avantor (AVTR)

• Market cap: $10.5B
• 1 day: 1.24%
• 5 days: 0.19%
• 1 month: -6.19%
• 3 months: -29.26%
• 6 months: -34.78%
• Year to date: -27.03%
• 1 year: -39.69%
• 5 years: 12.84%
• 10 years: 6.69%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

Employees: 13,500

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1.03% more ownership

Funds ownership: 99.39% [Q3] → 100.42% (+1.03%) [Q4]

5% less funds holding

Funds holding: 503 [Q3] → 478 (-25) [Q4]

17% less capital invested

Capital invested by funds: $17.5B [Q3] → $14.4B (-$3.05B) [Q4]

19% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 205

22% less first-time investments, than exits

New positions opened: 62 | Existing positions closed: 79

23% less funds holding in top 10

Funds holding in top 10: 13 [Q3] → 10 (-3) [Q4]

64% less call options, than puts

Call options by funds: $52.6M | Put options by funds: $145M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $18 16% upside
• Avg. target: $23 51% upside
• High target: $31 100% upside

7 analyst ratings

• positive: 6 86%
• neutral: 1 14%
• negative: 0 0%

Wells Fargo Brandon Couillard 24% 1-year accuracy 6 / 25 met price target	42% upside $22	Overweight Maintained	17 Apr 2025
Barclays Luke Sergott 21% 1-year accuracy 12 / 58 met price target	16% upside $18	Overweight Maintained	10 Apr 2025
Citigroup Patrick Donnelly 19% 1-year accuracy 6 / 31 met price target	16% upside $18	Neutral Maintained	4 Mar 2025
Morgan Stanley Tejas Savant 16% 1-year accuracy 3 / 19 met price target	62% upside $25	Overweight Maintained	10 Feb 2025
Raymond James Andrew Cooper 0% 1-year accuracy 0 / 16 met price target	55% upside $24	Outperform Reiterated	10 Feb 2025